SCHEMBL853122

SCHEMBL853122

CC=CCCCC(CCC)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 5/20 0.37
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
HDAC1 Q13547 3/20 0.33
HDAC2 Q92769 3/20 0.33
HDAC3 O15379 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853121 1.00 CTSK (0.37) CTSKCA1CA2HDAC1HDAC2
SCHEMBL29026540 0.95 CTSK (0.36) CTSKMEN1KMT2ACYP3A4FAAH
SCHEMBL29197061 0.89 CA1 (0.40) CTSKCA1CA2CYP3A4FAAH
SCHEMBL6832950 0.89 TAS1R3 (0.36) CTSKCA1CA2HDAC1HDAC2
SCHEMBL6832949 0.89 TAS1R3 (0.36) CTSKCA1CA2HDAC1HDAC2
SCHEMBL852191 0.84 CA2 (0.41) CTSKCA1CA2HDAC1HDAC2
SCHEMBL852192 0.84 CA2 (0.41) CTSKCA1CA2HDAC1HDAC2
SCHEMBL28146565 0.84 CTSK (0.45) CTSKCA1CA2HDAC1HDAC2
SCHEMBL10291076 0.83 HDAC1 (0.46) CTSKCA1CA2HDAC1HDAC2
SCHEMBL3433260 0.82 CTSK (0.33) CTSKCA1CA2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441720-B8 INHIBITORS OF SERINE PROTEASE, PARTICULARLY HEPATITIS C VIRUS NS3-NS4A PROTEASE, INCORPORATING A FUSED RING SYSTEM VERTEX PHARMA (US) 2012-03-28 EP disclosed
EP-1441720-A1 INHIBITORS OF SERINE PROTEASE, PARTICULARLY HEPATITIS C VIRUS NS3-NS4A PROTEASE, INCORPORATING A FUSED RING SYSTEM VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-08-04 EP disclosed
WO-2003035060-A1 INHIBITORS OF SERINE PROTEASE, PARTICULARLY HEPATITIS C VIRUS NS3-NS4A PROTEASE, INCORPORATING A FUSED RING SYSTEM VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-05-01 WO disclosed